|
SG11202100186RA
|
|
Methods and reagents for treating diabetes
|
|
CN106999597A
|
|
Method for treating and/or limiting diabetes de-velopment in the object with amyotrophic lateral sclerosis
|
|
US2015259416A1
|
|
Methods for treating and/or limiting development of diabetes
|
|
EP2970463A1
|
|
Methods for treating and/or limiting development of diabetes
|
|
EP2936151A1
|
|
Methods for treating and/or limiting development of diabetes
|
|
US2014033332A1
|
|
Methods for monitoring physiological status of a body organ
|
|
EP2707048A1
|
|
System and methods for motorized injection and aspiration
|
|
US2009060843A1
|
|
Non-Invasive In Vivo Imaging and Methods for Treating Type I Diabetes
|
|
US2009074743A1
|
|
Inositol pyrophosphates determine exocytotic capacity
|
|
US2007003986A1
|
|
Methods for identifying compounds for treating diabetes mellitus
|
|
EP1819354A2
|
|
Methods and compounds for treating diabetes
|
|
AU2003216860A1
|
|
Inhibition of the beta3 subunit of L-type Ca2+ channels
|
|
AU2002309083A1
|
|
Method for identifying drugs for the treatment of type ii diabetes
|
